{
  "id": 12378594,
  "title": "Conscience Announces Support for Two Projects Advancing Earlier Diagnosis and Treatment of Childhood Rare Diseases",
  "url": "https://urgent.news/2026/10/06/conscience-announces-support-for-two-projects-advancing-earlier",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-06T12:41:45.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/conscience-announces-support-for-two-projects-advancing-earlier-diagnosis-and-treatment-of-childhood-rare-diseases"
  },
  "original_language": "en",
  "account": null,
  "summary": "CureSPG50 and SickKids to pursue Phase 1/2 clinical trial of potential gene therapy for CLN7 Batten disease in Canada ThinkRare to expand AI-driven approach to help identify children with undiagnosed rare genetic diseases TORONTO — Conscience, a Canadian non-profit dedicated to enabling drug discovery through open science and collaboration for the advancement of accessible treatments, […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}